// App-Quantinova.ai

973 : An Analysis of Serological Response and Infection Outcomes Following Oxford Astra-Zeneca (azd1222) and Pfizer-Biontech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Pancreas Transplant Patients

Researchers

Presenter

  • A. Asderakis

Principal Investigators

  • U. Khalid

  • G. Koimtzis

  • M. Ponsford

  • L. Szab

  • L. Grant

  • S. Jolles

  • I. Humphreys

Medical Centers

  • Cardiff Transplant Unit, University Hospital for Wales, Cardiff, United Kingdom

  • Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom

  • Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved